← Leaderboards
John Karl Troyer
Pharmathene, Inc.
$1,263,753
Attributed
$1,263,753
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $422.4K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,263,753 · 1
By mechanism
U01$1,263,753 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Devices”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$199,696,645
- David Heimbrook · Leidos Biomedical Research, Inc.$141,696,528
- Daniel Ernest Ford · Johns Hopkins University$129,841,670
- Richard A Gibbs · Baylor College Of Medicine$118,056,644
Research focus
DevicesDoctor Of PhilosophyAntidotesDetectionAtropineAnimalsBinding (Molecular Function)BiologicalAnimal ModelBioscavengerBlood CirculationButyrylcholinesteraseCanadaBaseCaviaCessation Of LifeChemical AgentsClinical EfficacyClinical TrialsBiological ProductsConvulsantsConvulsionsCost EffectiveDose
Grant awards (5)
Novel Therapeutic Agent to Treat Nerve Agent Exposure after Civilian Attack$422,381
U01 · FY2010 · NS · contact PI
Novel Therapeutic Agent to Treat Nerve Agent Exposure after Civilian Attack$249,816
U01 · FY2009 · NS · contact PI
Novel Therapeutic Agent to Treat Nerve Agent Exposure after Civilian Attack$1
U01 · FY2008 · NS · contact PI
Novel Therapeutic Agent to Treat Nerve Agent Exposure after Civilian Attack$261,816
U01 · FY2007 · NS · contact PI
Novel Therapeutic Agent to Treat Nerve Agent Exposure after Civilian Attack$329,739
U01 · FY2006 · NS · contact PI